[Remote] MRD Clinical Account Executive, North Florida at Tempus

Florida, United States

Tempus Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Medical Devices, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

Precision MedicineHealthcare IndustryAIClinical CareReal-world EvidenceBusiness DevelopmentSalesMRD TestingKOL EngagementClient AcquisitionClient RetentionLaboratory Services AgreementsPartnership DevelopmentMarket AnalysisCompetitive LandscapeTerritory ManagementBudgetingGoal Setting

Questions & Answers

Common questions about this position

What qualifications are required for the MRD Clinical Account Executive role?

Candidates need a B.S. in life science, biology, business, or marketing, with an MBA preferred, and 3+ years of direct account management experience in a molecular diagnostic field.

What key skills are needed for this position?

The role requires proven ability in consultative selling of molecular diagnostic solutions, in-depth knowledge of oncology diagnostics reimbursement, strong communication and project management skills, advanced presentation skills, and proficiency in Microsoft Office and Salesforce.

Is this a remote position or does it require travel?

The role involves territory management in North Florida, including budgets and travel, focusing on major U.S. cancer centers, health systems, and community practices, indicating significant travel within the assigned territory.

What is the company culture like at Tempus?

Tempus emphasizes representing the company culture with integrity, respect, and trust to external and internal stakeholders.

What makes a strong candidate for this MRD Clinical Account Executive role?

Strong candidates have experience engaging executive-level stakeholders, knowledge of molecular diagnostics and MRD testing, consultative selling skills, and the ability to develop cross-functional relationships with minimal direction.

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI